From: Illness perceptions predict distress in patients with chronic kidney disease
Clinical outcomes | Pearson correlation | Sig (2-tailed) |
---|---|---|
Clinical markers | ||
eGFR (ml/min/1.73m2) |  − 0.374 | 0.000 |
Albumin (Serum) |  − 0.173 | 0.030 |
Haemoglobin A1c |  − 0.146 | 0.040 |
C-Reactive Protein mg/L | 0.155 | 0.040 |
Charlston Comorbidity Score | 0.111 | 0.119 |
Illness Perceptions | ||
IP-identity | 0.481 | 0.000 |
Timeline acute-chronic | 0.466 | 0.000 |
Consequences | 0.618 | 0.000 |
Personal control |  − 0.636 | 0.000 |
Treatment control |  − 0.594 | 0.000 |
Illness coherence |  − 0.272 | 0.000 |
Timeline cyclical | 0.448 | 0.000 |
Emotional representations | 0.619 | 0.000 |
Treatment beliefs | ||
BMQ general | 0.236 | 0.001 |
BMQ general overuse | 0.280 | 0.000 |
BMQ general harm | 0.143 | 0.044 |
BMQ specific | 0.324 | 0.000 |
BMQ specific necessity | 0.359 | 0.000 |
BMQ specific concerns | 0.211 | 0.003 |
Brief COPE-2 factor model | ||
Adaptive coping |  − 0.678 | 0.000 |
Maladaptive coping | 0.697 | 0.000 |
MARS5 score |  − 0.143 | 0.044 |